Guest speaker – Auto-immunity: Multiple Sclerosis Flashcards

1
Q

What type of disease is multiple sclerosis?

A

Chronic autoimmune disease of the central nervous system

It primarily affects the myelin sheath around neurons.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What happens to the myelin sheath in multiple sclerosis?

A

Destruction of myelin sheath around neurons

This destruction leads to lesions that can be seen by MRI.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is sclerosis in the context of multiple sclerosis?

A

Scar tissue formed from nerve damage

It results in impaired signal transmission along nerves.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

List some common symptoms of multiple sclerosis.

A
  • Pain
  • Fatigue
  • Tingling
  • Impaired gait
  • Vision problems
  • Bladder problems
  • Dizziness
  • Cognitive and mood problems
  • Paralysis

Symptoms vary among individuals.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How does inflammation affect the immune response in multiple sclerosis?

A

Increased recruitment of other immune cells

Inflammation leads to the crossing of lymphocytes across the blood-brain barrier.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What role do auto-reactive CD4+ T cells play in multiple sclerosis?

A

They reencounter their specific antigen presented by MHC II in macrophages, leading to demyelination

These cells contribute to the autoimmune nature of MS.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is relapsing-remitting MS?

A

Episodes of relapses followed by periods of remission, affecting ~85% of patients

Symptoms may improve during remission but can relapse.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What characterizes primary progressive MS?

A

Steady increase in disability with no relapse or remission

This type progresses continuously without improvement.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe progressive-relapsing MS.

A

Steady increase in disability with subsequent relapses and no remissions

It combines elements of both progressive and relapsing forms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is secondary progressive MS?

A

Initial relapsing-remitting MS that begins to steadily increase in disability without periods of remission

This often occurs after a period of relapsing-remitting MS.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What methods are used to diagnose MS?

A
  • MRI
  • Vision, coordination, sense of balance tests
  • Spinal tap/lumbar puncture
  • Blood tests
  • Evoked potential tests

These tests help rule out other diseases and assess CNS inflammation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the purpose of IFNb therapy in MS treatment?

A

Reduces relapses by ~30% through various mechanisms

Mechanisms include controlling cytokine secretion and reducing lymphocyte migration.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the effects of corticosteroid therapy in MS?

A
  • Immunosuppressant properties
  • Reduces inflammation caused by pro-inflammatory cytokines
  • Increases apoptosis in lymphocytes
  • Reduces migration of leukocytes to the brain

This therapy helps manage acute exacerbations.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How effective is dimethyl fumarate therapy in MS?

A

Reduces relapses by 50%

It is taken as oral pills and has fewer side effects compared to some other treatments.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is a potential mechanism of dimethyl fumarate therapy?

A
  • Anti-inflammatory effects
  • Suppresses production of pro-inflammatory cytokines
  • Stimulates Tregs
  • Induces changes in APC maturation and function

This therapy targets multiple aspects of the immune response.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is a concern with many MS therapies?

A

They can lead to immunosuppression

This may increase the risk of infections and other complications.

17
Q

What factors contribute to MS progression?

A

Multiple factors including genetic, environmental, and immune system components

Understanding these factors is crucial for managing the disease.

18
Q

Potential mechanisms of IFNb therapy

A

o Control secretion of pro & anti-inflammatory cytokines
o Reducing ability of lymphocytes to cross blood-brain barrier
o Affect APC function
o May inhibit some T cell differentiation & increase T cell apoptosis